GBIO - Bathi operasional EBITDA Generation Bio
Current royalties from the sale of non-viral DNA delivery methods provide short-term stability for Generation Bio Co. (GBIO), while long-term success relies on attracting elite geneticists and large-scale R&D. The absolute EBITDA trend visualizes this balance, and 0.00 indicates the current level of the metric. Developments in bypassing the immune response via innovative lipid nanoparticles and ceDNA further strengthen the foundation.
Ringkesan rincian data analitis Generation Bio (GBIO)
- kuotasi lan prakiraan analis:
- statistik kapitalisasi pasar:
- indikator nilai buku ekuitas:
- indikator total utang lan likuiditas perusahaan:
Utang marang Modal Generation Bio Co.|GBIO - Utang jangka dawa marang ekuitas|Rasio utang jangka cendhak marang modal Generation Bio Co|GBIO - Gunggung utang perusahaan|Rasio utang marang aset resik Generation Bio|GBIO - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Generation Bio|Koefisien jangkoan perantara generationbio.com
- rincian asil keuangan lan kelipatan valuasi:
GBIO - Bathi resik perusahaan|Bathi resik sing dikarepake Generation Bio Co.|GBIO - Koefisien rega marang bathi|Pangali mangsa ngarep rega marang bathi Generation Bio Co|GBIO - Pangali PEG|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Generation Bio|GBIO - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi resik saben siji saham sajrone rolas wulan pungkasan Generation Bio|GBIO - Bathi resik saben saham sajrone 12 wulan pungkasan|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan generationbio.com|GBIO - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep Generation Bio Co.
Pambiji fundamental perusahaan:Generation Bio Co.
Generation Bio Co. (GBIO) strategic alliances to develop non-viral DNA delivery systems drive the cash flow dynamics reflected in the net operating income before depreciation. This indicator measures core business efficiency excluding depreciation and taxes, allowing investors to assess the company's actual ability to generate cash and avoid overpaying for the asset amid macroeconomic cooling.
Karo sapa Generation Bio Co. saingan
Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi TEM|Qiagen N.V. - Bathi operasional EBITDA|IONS - Bathi operasional EBITDA|RGEN (Repligen) - Bathi operasional sadurunge ngurangi amortisasi|RNA: Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|CRSP (CRISPR Therapeutics Corp) - Bathi operasional EBITDA|GeneDx Corp (WGS) - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Ultragenyx Pharmaceutical (RARE)|BEAM - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Sarepta SRPT|TWST: Bathi operasional sadurunge amortisasi|TXG: Bathi operasional sadurunge ngurangi amortisasi|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi NTLA (Intellia Corp)|STOK: Bathi operasional EBITDA|BLFS (biolifesolutions.com) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|WVE (Wave Life Sciences Ltd.) - Bathi operasional EBITDA|Maze Therapeutics, Inc. (MAZE) - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Sionna Pharma (SION)|PRME - Bathi sadurunge bunga, pajak, lan amortisasi|Taysha Gene Therapies - Bathi operasional sadurunge ngurangi amortisasi|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi QURE|MeiraGTx - Bathi operasional EBITDA|REGENXBIO Inc (RGNX) - Bathi operasional sadurunge ngurangi amortisasi|Solid Bio (SLDB) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi sadurunge bunga, pajak, lan amortisasi Ocugen Pharma (OCGN)|Bathi operasional sadurunge ngurangi amortisasi PACB|benitec.com (BNTC) - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi operasional EBITDA DSGN|Rocket Pharma (RCKT) - Bathi operasional sadurunge potongan amortisasi|Bathi operasional EBITDA FDMT (4D Molecular Therapeutics Inc)|Lexeo Therapeutics Inc. - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Korro Bio, Inc - Bathi operasional EBITDA|Pendapatan operasional sadurunge ngurangi amortisasi editasmedicine.com EDIT|Silence Therapeutics plc (SLN) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi sadurunge bunga, pajak, lan amortisasi ProQR Therapeutics (PRQR)|CDXS (Codexis Inc) - Bathi operasional EBITDA|Bathi operasional sadurunge amortisasi SGMO (Sangamo BioSciences)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Nautilus Biotechnology (NAUT)|metagenomi.co - Bathi operasional sadurunge amortisasi|Bathi operasional EBITDA DTIL (Precision BioSciences, Inc.)|Bathi operasional EBITDA Boundless Bio Inc. BOLD|Exicure Corp - Bathi operasional EBITDA|Bathi operasional sadurunge potongan amortisasi Imunon, Inc. (IMNN)|PHIO: Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi Mustang Bio (MBIO)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi TransCode Therapeutics Inc.|Bathi operasional sadurunge amortisasi BNGO (Bionano)|Bathi operasional EBITDA APDN|BLUE - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi ImmunoPrecise Antibodies Ltd. IPA|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi OMGA|Singular Genomics - Bathi operasional EBITDA|RGLS - Bathi operasional EBITDA|SYRS (Syros) - Bathi operasional sadurunge ngurangi amortisasi|TBIO: Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|TCON (TRACON Pharmaceuticals) - Bathi operasional EBITDA|unitybiotechnology.com (UBX) - Pendapatan operasional sadurunge ngurangi amortisasi
